AustinPx

About

AustinPx is a contract development and manufacturing organization (CDMO) based in Georgetown, Texas. Founded in 2007, the company specializes in pharmaceutical formulation, process development, and GMP manufacturing of oral dosage forms from preclinical through Phase II stages. AustinPx utilizes its proprietary KinetiSol™ Technology, an advanced platform designed to enhance the solubility of poorly soluble active pharmaceutical ingredients (APIs). The company offers a range of services that support early drug development, including preclinical and formulation development, analytical services, and process development. AustinPx emphasizes a client-centric approach, providing flexible and responsive solutions tailored to the unique needs of each project. With a background as a former drug sponsor, AustinPx collaborates closely with clients, from small innovators to large pharmaceutical companies. The firm has received recognition for its innovative technology and recently launched the KinetiLease™ program, allowing firms to lease KinetiSol™ equipment for their research and development needs.